BUZZ-Indian Pharma stocks drop on US tariff fears

India's Nifty pharma index .NIPHARM slides 2% after the U.S. President Donald Trump said he intends to levy import tariffs of 25% or more on pharmaceuticals

NIPHARM drops most among 13-major sectoral indexes; heavyweights Sun Pharma SUN.NS, Dr. Reddy's REDY.NS and Cipla CIPL.NS down 1.7%, 3.8% and 1.74%, respectively

18 of the 20 index constituents are trading in red

SUN, REDY, CIPL among top drags on the benchmark Nifty 50 .NSEI, which is down 0.1%

Indian drugmakers derive about 31% of their revenue from the U.S.

NIPHARM hits lowest in seven months, it has dropped ~15% since all-time high in October 9